These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 15338948

  • 1. Virtual screening in lead discovery and optimization.
    Jain AN.
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):396-403. PubMed ID: 15338948
    [Abstract] [Full Text] [Related]

  • 2. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 3. Docking and scoring in virtual screening for drug discovery: methods and applications.
    Kitchen DB, Decornez H, Furr JR, Bajorath J.
    Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
    [Abstract] [Full Text] [Related]

  • 4. Integrating virtual screening in lead discovery.
    Oprea TI, Matter H.
    Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
    [Abstract] [Full Text] [Related]

  • 5. Structure-guided fragment screening for lead discovery.
    Verdonk ML, Hartshorn MJ.
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
    [Abstract] [Full Text] [Related]

  • 6. Integrating molecular design resources within modern drug discovery research: the Roche experience.
    Stahl M, Guba W, Kansy M.
    Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
    [Abstract] [Full Text] [Related]

  • 7. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY, Itai A.
    J Med Chem; 2004 Sep 23; 47(20):4818-28. PubMed ID: 15369385
    [Abstract] [Full Text] [Related]

  • 8. Virtual screening strategies in drug discovery.
    McInnes C.
    Curr Opin Chem Biol; 2007 Oct 23; 11(5):494-502. PubMed ID: 17936059
    [Abstract] [Full Text] [Related]

  • 9. Novel technologies for virtual screening.
    Lengauer T, Lemmen C, Rarey M, Zimmermann M.
    Drug Discov Today; 2004 Jan 01; 9(1):27-34. PubMed ID: 14761803
    [Abstract] [Full Text] [Related]

  • 10. Towards improving compound selection in structure-based virtual screening.
    Waszkowycz B.
    Drug Discov Today; 2008 Mar 01; 13(5-6):219-26. PubMed ID: 18342797
    [Abstract] [Full Text] [Related]

  • 11. Fragment-based lead discovery: a chemical update.
    Erlanson DA.
    Curr Opin Biotechnol; 2006 Dec 01; 17(6):643-52. PubMed ID: 17084612
    [Abstract] [Full Text] [Related]

  • 12. The discovery of Kv1.5 blockers as a case study for the application of virtual screening approaches.
    Pirard B, Brendel J, Peukert S.
    J Chem Inf Model; 2005 Dec 01; 45(2):477-85. PubMed ID: 15807513
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P, Saxena AK.
    J Chem Inf Model; 2006 Dec 01; 46(1):39-51. PubMed ID: 16426038
    [Abstract] [Full Text] [Related]

  • 14. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y, Schneider G.
    Nat Rev Drug Discov; 2008 Aug 01; 7(8):667-77. PubMed ID: 18636071
    [Abstract] [Full Text] [Related]

  • 15. A knowledge-based weighting approach to ligand-based virtual screening.
    Stiefl N, Zaliani A.
    J Chem Inf Model; 2006 Aug 01; 46(2):587-96. PubMed ID: 16562987
    [Abstract] [Full Text] [Related]

  • 16. Structure-based approaches to drug design and virtual screening.
    Waszkowycz B.
    Curr Opin Drug Discov Devel; 2002 May 01; 5(3):407-13. PubMed ID: 12058616
    [Abstract] [Full Text] [Related]

  • 17. Recent advances in computer-aided drug design.
    Song CM, Lim SJ, Tong JC.
    Brief Bioinform; 2009 Sep 01; 10(5):579-91. PubMed ID: 19433475
    [Abstract] [Full Text] [Related]

  • 18. A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication.
    Bender A, Glen RC.
    J Chem Inf Model; 2005 Sep 01; 45(5):1369-75. PubMed ID: 16180913
    [Abstract] [Full Text] [Related]

  • 19. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J, Rarey M.
    J Chem Inf Model; 2009 Apr 01; 49(4):800-9. PubMed ID: 19354328
    [Abstract] [Full Text] [Related]

  • 20. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC.
    Curr Opin Drug Discov Devel; 2008 May 01; 11(3):356-64. PubMed ID: 18428089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.